Showing 25–36 of 59 results
-
CALBRICK PLUS
✅ CALBRICK PLUS
Composition:
- Calcitriol 0.25 mcg
- Calcium Carbonate 500 mg
- DHA (Docosahexaenoic Acid) 120 mg
- EPA (Eicosapentaenoic Acid) 180 mg
- Elemental Boron 1.5 mg
- Folic Acid 400 mcg
- Methylcobalamin 1500 mcg
-
CALBRICK PRO
Background:
- Calcitriol
Enhances intestinal calcium absorption and renal reabsorption, supporting blood calcium levels and bone mineralization. - Calcium Carbonate
Essential for bone strength; helps reduce fracture risk by preventing calcium deficiency. - EPA & DHA (Omega-3 Fatty Acids)
Modulate inflammatory pathways, reduce osteoclast activity, and promote osteoblast function—crucial for bone remodeling. - Boron
A trace mineral that helps maintain calcium, magnesium, and phosphorus levels in bones. - Folic Acid & Methylcobalamin (Vitamin B12)
Work together to reduce homocysteine levels, minimizing the risk of bone weakening and fractures. - Note: Zinc depletion can reduce the body’s response to calcitriol therapy.
- Calcitriol
-
CELLI Q TEN GOLD
DESCRIPTION:
CELLI Q-TEN GOLD is a specially formulated tablet containing Coenzyme Q10, L-Carnitine, Lycopene, L- Arginine, Selenium, zinc & Folic acid. It is designed for use in deficiency states and medical conditions including:
- Cardiovascular disease
- Neuromuscular disorders
- Hypertension
- Periodontal disease
- Hyperthyroidism
- Male infertility
- AIDS
-
CELLI Q-10
Description:
Celli Q 10 is a scientifically developed formulation designed to support respiratory health in patients with asthma and Chronic Obstructive Pulmonary Disease (COPD). Both conditions are associated with oxidative stress and REDOX imbalance. Celli Q 10 combines potent antioxidants and nutrients to help restore balance and enhance respiratory function.
-
ESOBRICK 40
Rated 5.00 out of 5Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-D
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-IT
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
ESOBRICK-L
Background
Gastroesophageal Reflux Disease (GERD) and Functional Dyspepsia are highly prevalent gastrointestinal disorders worldwide. These conditions often coexist, making clinical differentiation difficult.
- The global prevalence of GERD is around 99%, and Functional Dyspepsia affects 20–30% of the general population.
- Proton Pump Inhibitors (PPIs), alone or combined with prokinetic agents, are proven effective in relieving symptoms and improving quality of life in acid-related disorders.
-
FLAXMOX CV
Background:
The combination Amoxicillin + Clavulanic Acid + Lactic Acid Bacillus is a triple formulation that includes two drug components and one probiotic. Here’s a clear breakdown
a) Amoxicillin
A broad-spectrum penicillin-type (β-lactam) antibiotic.
It works by inhibiting bacterial cell wall synthesis, leading to bacterial death.
Active against many Gram-positive and some Gram-negative bacteria.
b) Clavulanic Acid
A β-lactamase inhibitor (similar role to tazobactam).
It prevents bacterial enzymes (β-lactamases) from destroying amoxicillin, making the antibiotic more effective against resistant strains.
c) Lactic Acid Bacillus
A probiotic (friendly bacteria) added to prevent or reduce antibiotic-associated diarrhea and restore the natural gut flora disturbed by antibiotics.
-
GLOMUNE IV
Background
GLOMUNE IV is a clear, colorless to almost colorless sterile solution of L-Alanyl-L-Glutamine, a dipeptide stable form of glutamine used in parenteral nutrition (TPN).
-
GLOMUNE SACHETS
Background
L‑Glutamine in granule form, which can be used orally as well as through tube feeding. L‑Glutamine, an immuno‑enhancer, serves as an effective fuel for intestinal cells and improves gut function. It is indicated for various critical disorders as under:

